CELL & GENE THERAPY INSIGHTS

Feb 2018. Vol 4 Issue 2

Feb 2018

FEATURING

Issue Spotlight: Latest Developments in Viral and Non-Viral Vector Manufacturing
Other articles
Webinar

Spotlight

Latest Developments in Viral and Non-Viral Vector Manufacturing

Feb 2018
Guest Editor:
Nathalie Clement, Associate Professor, Courtesy Faculty at University of Florida
Nathalie Clement
Associate Professor, Courtesy Faculty at University of Florida

Expert Insight


Innovator Insight

Addressing scaling-up limitations: optimized PEI-mediated production of clinical grade viral vectors

Dr Alengo Nyamay’antu,
Valérie Kedinger,
Patrick Erbacher
26 March 2018
Innovator Insight

Interview


Other articles

Commercial Insights

Cell & Gene Therapy Commercial Insight – February 2018

Mark Curtis,
Richard Philipson
15 March 2018
Commercial Insights

Webinars

Commercial-scale viral vector manufacture: technical challenges & strategic implications

Commercial-scale viral vector manufacture: technical challenges & strategic implications

Michael Kelly
Michael Kelly, Director, Asset Leadership, Gene Therapy at Biogen Idec
Clive Glover
Clive Glover, Director, Strategy at Pall Biotech
Richard Snyder
Richard Snyder, CSO at Thermo Fisher Scientific
14 February 2018
Webinar